Nomoto, M., Hasunuma, T., Cai, C., Suzuki, I., Mikubo, A., Funasaka, S., . . . Yasuda, S. (2024). Effects of Food, Gastric Acid Reduction, and Strong CYP3A Induction on the Pharmacokinetics of Tasurgratinib, a Novel Selective Fibroblast Growth Factor Receptor Inhibitor. Journal of clinical pharmacology, 64(12), 1541-1551. https://doi.org/10.1002/jcph.6104
Chicago Style (17th ed.) CitationNomoto, Maiko, Tomoko Hasunuma, Cuiyuan Cai, Ippei Suzuki, Ayano Mikubo, Setsuo Funasaka, Yohei Otake, Kenya Nakai, and Sanae Yasuda. "Effects of Food, Gastric Acid Reduction, and Strong CYP3A Induction on the Pharmacokinetics of Tasurgratinib, a Novel Selective Fibroblast Growth Factor Receptor Inhibitor." Journal of Clinical Pharmacology 64, no. 12 (2024): 1541-1551. https://doi.org/10.1002/jcph.6104.
MLA (9th ed.) CitationNomoto, Maiko, et al. "Effects of Food, Gastric Acid Reduction, and Strong CYP3A Induction on the Pharmacokinetics of Tasurgratinib, a Novel Selective Fibroblast Growth Factor Receptor Inhibitor." Journal of Clinical Pharmacology, vol. 64, no. 12, 2024, pp. 1541-1551, https://doi.org/10.1002/jcph.6104.